←
DrPratibhamycology1,014 posts
D

DrPratibhamycology

@thoughtruminant

Associate Professor, Clinical Microbiology, ILBS, working in Mycology and infectious diseases, transplant ID, Liver ID, OncoID

◷ Joined July 2016▧ 132 Photos and videos
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Nov 11

A Moment of Immense Pride for ILBS and the Global Hepatology Community! The Institute of Liver and Biliary Sciences (ILBS) is delighted to celebrate a significant recognition at AASLD 2026, where the American Association for the Study of Liver Diseases (AASLD) presented the prestigious ‘Shiv K. Sarin Merit Award’ to investigators whose abstracts were selected as outstanding research contributions in the fields of Acute-on-Chronic Liver Failure (ACLF) and Portal Hypertension. Named in honour of Professor Shiv K. Sarin, whose pioneering work has significantly advanced these two important fields of hepatology, the award recognises scientific excellence and celebrates research that contributes to shaping the future of liver disease management. This recognition is particularly meaningful as it carries forward Professor Sarin’s enduring legacy while encouraging the next generation of researchers to pursue innovative, impactful work in hepatology. Heartiest congratulations to @JustSagnik & Dr Jayashree Biswas, the award recipients! Our sincere appreciation to AASLD for this distinguished recognition and for honouring Professor Shiv K. Sarin’s exceptional contributions to liver research. A proud moment for ILBS. A lasting legacy for hepatology. #ILBS #AASLD2026 #ShivKSarinMeritAward #Hepatology #ACLF #PortalHypertension #LiverResearch @AASLDtweets @APASLnews

Post attachment
@QCI_NABH avatar
⟳ DrPratibhamycology retweeted
@QCI_NABH@NABH_QCI·Oct 28

QCI-NABH successfully hosted the 9th Edition of the NABH Regional Assessor Conclave on 27 October 2026 at Novotel New Delhi City Centre, bringing together NABH Assessors and QPAC (Quality Promotion and Advisory Council) Members from across the region for meaningful engagement, knowledge exchange, and collaborative learning. The conclave featured focused discussions on: * Quality Bharat Mission and the Gunvatta initiatives driving excellence in healthcare * Updates on NABH quality initiatives and strategic programmes * Emerging accreditation and certification programmes, revised standards, and new service lines * Assessor performance, assessment trends, common non-conformities (NCs), and best practices in report writing * Digital transformation initiatives, including the AI-enabled Modular Platform * Assessor professionalism, Code of Conduct, effective communication, and assessment best practices * Recognition of quality initiatives and assessor excellence The event witnessed active participation and engaging discussions, enriched by the experiences, perspectives, and best practices shared by the NABH Assessor community and QPAC Members. The conclave reaffirmed the vital role played by NABH Assessors in advancing quality, patient safety, consistency, and continual improvement across healthcare organisations. QCI-NABH remains committed to empowering its assessor community through continuous learning, professional development, and collaborative engagement, further strengthening the pursuit of excellence in healthcare accreditation across the country. @QualityCouncil

Post attachmentPost attachmentPost attachmentPost attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Oct 10

Proud moment for ILBS! 🌟🇮🇳 Five Faculty scientists from the Institute of Liver and Biliary Sciences (ILBS), New Delhi, feature in the Stanford–Elsevier World’s Top 2% Scientists List 2026, recognising their impactful contributions to research and scientific excellence. Congratulations to our outstanding faculty for bringing laurels to ILBS and advancing medical science! 👏 #ILBS #Top2PercentScientists #ResearchExcellence #MedicalResearch

Post attachmentPost attachmentPost attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Sep 20

Institute of Liver & Biliary Sciences, New Delhi is observing Patient Safety Week 2026 from 14–20 September 2026, in alignment with World Patient Safety Day on 17 September. This year’s theme, “Self Care for Non-Communicable Diseases,” highlights the importance of empowering patients and communities to actively participate in their own health and safety. A week-long series of activities were conducted at ILBS, bringing together doctors, nurses, hospital staff, patients, attendants, and the community. ✨ Key activities included: 🛡️ Patient Safety Pledge Ceremony 💊 Training on Safe Medicine 🩺 Health screening camps for the community and security staff. 💡 Safe medication counselling for patients with chronic diseases 🎭 Nukkad Natak on self-management, treatment adherence, recognition of adverse events and safe transitions of care 🧠 Patient Safety Quiz Competition 📋 Medication rationalisation and prescription audit The programme reflects ILBS’s continued commitment to patient-centred care, medication safety, self-care, awareness and reduction of preventable harm under the guidance of Director Dr S K sarin. The Medical Operations team lead by Head Operations Dr Arun Kumar Rastogi successfully conducted these activities. Together, let us make patient safety everyone’s responsibility. Safe care. Informed patients. Better outcomes. 💙 #PatientSafetyWeek #WorldPatientSafetyDay #PatientSafety2026 #ILBS #PatientSafety #SafeMedication #SelfCare #NCDs #PatientCentredCare #HealthcareSafety #ILBSDelhi @ArunRastogi9 @CMODelhi @drpankajbjp @MoHFW_INDIA

Post attachmentPost attachmentPost attachmentPost attachment
DrPratibhamycology avatar
DrPratibhamycology@thoughtruminant·Sep 20

🎉 Honoured & grateful! Elected as a Member of the Executive Council of the Indian Association of Medical Microbiologists (IAMM). My sincere gratitude to all the members for their trust and support. Congratulations to all the newly elected EC members! 🙏 #IAMM #Microbiology

Post attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Sep 20

🏆 A proud and inspiring moment for ILBS! AHPI award for “Liver and ILBS” Heartiest congratulations to Dr. Shiv Kumar Sarin, Director, Institute of Liver and Biliary Sciences, on being honoured with the prestigious “Healthcare Luminary of India Award” by the Association of Healthcare Providers (India) – AHPI. A well-deserved recognition of his remarkable contributions to healthcare, hepatology, medical education and research, and his unwavering commitment to advancing patient care. 🌟 A moment of pride for ILBS and Indian healthcare! #HealthcareLuminary #AHPI #DrShivSarin #ILBS #HealthcareLeadership #Hepatology #HealthcareIndia #ProudMoment

Post attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Jun 5

🌍 Happy World Environment Day 2026! In line with this year’s theme, “Inspired by Nature. For Climate. For Our Future”, a tree plantation drive was organized at ILBS to reaffirm our commitment to environmental sustainability and climate action. We were honored to have Ms. Sylviane Pied, Scientific Attaché (France), join us for the plantation activity, highlighting the importance of global collaboration in building a greener and healthier future. Together, let us nurture nature, protect our environment, and create a sustainable world for generations to come. 🌱🌳 #WorldEnvironmentDay #EnvironmentDay2026 #TreePlantation #ILBS #ClimateAction #Sustainability #InspiredByNature #NowForClimate @ArunRastogi9 @IFCPAR @MYBharatHQ @MoHFW_INDIA @gupta_rekha @drpankajbjp

Post attachmentPost attachmentPost attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·May 15

Celebrating four decades of Indo-French scientific collaboration! 🇮🇳🇫🇷 The 40th Anniversary celebration of CEFIPRA (@40) and the launch of IFI’s #ScientificThursdays was successfully held at INSA, New Delhi, bringing together leaders from academia, research, and diplomacy. The event was graced by H.E. Mr Thierry Mathou, Ambassador of France to India, Prof. Abhay Karandikar, Secretary, DST (GoI) & CEFIPRA Indian Co-Chair, Dr Shekhar Mande, President, Infian National Science Academy, Prof. Nitin Seth Director, CEFIPRA A highlight of the evening was the special plenary lecture by Padma Bhushan Dr Shiv Kumar Sarin, ILBS, on “Liver Fat Flames and Frames the Body”. The celebration marked a significant milestone in strengthening Indo-French partnerships in science, innovation, and research collaboration. #CEFIPRAat40 #IndoFrenchPartnership #ScientificThursdays #ResearchCollaboration #Innovation #ILBS #ScienceDiplomacy #IndiaFrance @IFCPAR @FranceinIndia @karandi65 @IndiaDST @insa_academy @shekhar_mande

Post attachmentPost attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·May 1

📋 Day 14 | Understanding your FibroScan result “NAFLD/MASLD cannot be tackled at the hospital level alone. It must be detected in the community — before symptoms appear, before damage is done, before it is too late.” FibroScan is the tool that makes this possible. Without community-level screening using tools like FibroScan, the majority of fatty liver cases in India will remain undetected until irreversible damage occurs. Know about the Fibroscan results: Liver Stiffness (Fibrosis score): 🟢 F0 — No fibrosis. Your liver is healthy. Keep your habits strong. 🟢 F1 — Minimal fibrosis. Reversible. Lifestyle changes now make a huge difference. 🟡 F2 — Moderate fibrosis. Needs hepatologist review and active management. 🟠 F3 — Severe fibrosis. Urgent hepatologist consultation needed. 🔴 F4 — Cirrhosis. Immediate specialist care essential. Liver Fat (CAP score): 🟢 S0 — No significant steatosis. Normal. 🟡 S1 — Mild steatosis (11–33% of liver cells affected). Diet changes needed. 🟠 S2 — Moderate steatosis (34–66%). Active intervention required. 🔴 S3 — Severe steatosis (>67%). Urgent hepatologist review. The most important thing about your FibroScan result: F1 and F2 — and even S1, S2, S3 — are reversible. With diet, exercise, and medical guidance. @RewariBharat @ArunRastogi9 @gaurav25051981 @thoughtruminant @SukritiBaweja @ChiefSecyDelhi @LtGovDelhi @CMODelhi @ICMRDELHI @MoHFW_INDIA @Sangram_Sanjeet

Post attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·May 2

🎉 Day 15 of 15 | WE DID IT. 15 days ago, we asked you to make one small change. You showed up. Every. Single. Day. Look what we did together over these 15 days: ✅ Day 1 — Launched the campaign with the Hon’ble LG of Delhi ✅ Day 2 — Learned what the liver actually does ✅ Day 3 — Swapped one sugary drink for water ✅ Day 4 — Busted the fatty liver myth ✅ Day 5 — Walked 20 minutes daily ✅ Day 6 — Ate liver-friendly foods ✅ Day 7 — Screened ourselves ✅ Day 8 — Understood sugar and fibrosis ✅ Day 9 — Reached the midpoint — still going ✅ Day 10 — Learned to catch cirrhosis early ✅ Day 11 — Heard patient stories of hope ✅ Day 12 — Took liver health to the workplace ✅ Day 13 — Faced the truth about alcohol ✅ Day 14 — Saw the science behind screening ✅ Day 15 — YOU are here. Challenge complete. 💚 15 days was just the start. #WorldLiverDay2026 #15DayLiverChallenge #ChallengeComplete #SolidHabitsStrongLiver #ILBS #StrongLiver @RewariBharat @ArunRastogi9 @gaurav25051981 @thoughtruminant @SukritiBaweja @ChiefSecyDelhi @LtGovDelhi @CMODelhi @ICMRDELHI @MoHFW_INDIA @Sangram_Sanjeet

Post attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Apr 24

🩺 दिन 7 / 15 | अपनी जांच करवाएं फैटी लिवर में शुरुआत में कोई लक्षण नहीं होता। जानने का एकमात्र तरीका है — जांच। ALT क्या है? ALT (एलानिन एमिनोट्रांसफेरेज़) मुख्य रूप से लिवर में पाया जाने वाला एंज़ाइम है। जब लिवर कोशिकाएं क्षतिग्रस्त होती हैं, ALT खून में आ जाता है। ✅ सरल। सस्ता। अत्यंत संवेदनशील। ✅ हेपेटाइटिस, सिरोसिस और दवा-जनित लिवर क्षति जल्दी पकड़े ✅ हर किसी को कम से कम एक बार ALT जांच करानी चाहिए ✅ जोखिम वाले लोगों को नियमित रूप से करानी चाहिए FibroScan क्या है? FibroScan कम-आवृत्ति अल्ट्रासाउंड तरंगों का उपयोग करके लिवर की कठोरता और फैट की मात्रा कुछ ही मिनटों में मापता है। ✅ 100% दर्दरहित — कोई सुई नहीं, कोई बायोप्सी नहीं ✅ कोई विकिरण नहीं ✅ तुरंत परिणाम ✅ बताता है अभी आपके लिवर में कितना फैट और फाइब्रोसिस है आज किसे जांच करानी चाहिए? 🔴 डायबिटीज़ के मरीज़ — इंसुलिन प्रतिरोध सीधे फैटी लिवर बनाता है 🔴 अधिक वज़न / मोटापे वाले — विशेषकर पेट की चर्बी वाले 🔴 परिवार में लिवर रोग, सिरोसिस या लिवर कैंसर का इतिहास 🔴 जिनके LFT में पहले गड़बड़ी आई हो (उच्च ALT/AST) 🔴 नियमित शराब पीने वाले 🔴 लंबे समय से दवाएं लेने वाले 🔴 40 वर्ष से अधिक आयु के लोग 🔴 मेटाबोलिक सिंड्रोम या उच्च ट्राइग्लिसराइड वाले #WorldLiverDay2026 #FibroScan #लिवरजांच #EarlyDetection #SolidHabitsStrongLiver #ILBS #लिवरस्वास्थ्य #StrongLiver @RewariBharat @ArunRastogi9 @gaurav25051981 @thoughtruminant @ChiefSecyDelhi @LtGovDelhi @CMODelhi @ICMRDELHI @MoHFW_INDIA @Sangram_Sanjeet

Post attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Apr 24

🩺 Day 7 of 15 | Screen Yourself Fatty liver has NO symptoms until it’s advanced. The only way to know is to TEST. What is ALT? ALT (Alanine Aminotransferase) is an enzyme found mainly in the liver. When liver cells are damaged, ALT leaks into the bloodstream. ✅ Simple. Cheap. Highly sensitive. ✅ Can identify hepatitis, cirrhosis, and drug-induced liver injury early ✅ Everyone should get it measured at least ONCE ✅ Those at risk need it regularly What is FibroScan? FibroScan uses low-frequency ultrasound waves to measure liver stiffness and fat content — in just a few minutes. ✅ 100% Painless — no needle, no biopsy ✅ No radiation ✅ Instant results ✅ Tells you exactly how much fat and fibrosis your liver has RIGHT NOW Who should get tested TODAY? 🔴 Diabetics — insulin resistance directly causes fatty liver 🔴 Overweight / obese individuals — especially with central belly fat 🔴 Family history of liver disease, cirrhosis, or liver cancer 🔴 Anyone with deranged liver function tests (high ALT/AST) 🔴 Regular alcohol consumers 🔴 Anyone on long-term medications 🔴 Individuals over 40 years of age 🔴 Those with metabolic syndrome or high triglycerides #WorldLiverDay2026 #FibroScan #LiverScreening #EarlyDetection #SolidHabitsStrongLiver #ILBS #StrongLiver #ALT @RewariBharat @ArunRastogi9 @gaurav25051981 @thoughtruminant @ChiefSecyDelhi @LtGovDelhi @CMODelhi @ICMRDELHI @MoHFW_INDIA @Sangram_Sanjeet

Post attachment
ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Apr 21

🏋️ “The body is not a machine you push to its limits. It is a living system that responds to care, rest, and the right nourishment. Eat Regional, Seasonal and Original.” — @Sangram_Sanjeet , wrestler & fitness icon at ILBS #WorldLiverDay2026 His journey from illness to the wrestling mat = the most powerful proof of #SolidHabitsStrongLiver 💚 ▶️ youtu.be/4vN46wjJYGE #ILBS #15DayLiverChallenge #StrongLiver #LiverHealth @RewariBharat @ArunRastogi9 @gaurav25051981 @thoughtruminant @SukritiBaweja @htevethia @satenderpsingh @ChiefSecyDelhi @LtGovDelhi @CMODelhi @ICMRDELHI @MoHFW_INDIA @Sangram_Sanjeet @DrKanicaKaushal @NTrehanpati @GayatriRamakri4 @AnupamaParasar @ashok_doctor @MaiwallRakhi

ILBS_University avatar
⟳ DrPratibhamycology retweeted
ILBS_University@ILBS_India·Apr 21

🏋️ “शरीर एक मशीन नहीं है जिसे आप अपनी सीमाओं से परे धकेलें। यह एक जीवित तंत्र है जो देखभाल, आराम और सही पोषण से बेहतर होता है। क्षेत्रीय, मौसमी और प्राकृतिक भोजन करें।” पहलवान श्री संग्राम सिंह ने #WorldLiverDay2026 पर ILBS में अपनी ज़िंदगी की सबसे प्रेरक कहानी सुनाई — बीमारी से कुश्ती के मैदान तक का सफर। रोज़ की छोटी-छोटी आदतों ने उनकी ज़िंदगी बदल दी। आपकी भी बदल सकती है। 💚 ▶️ youtu.be/4vN46wjJYGE #SolidHabitsStrongLiver #ILBS #15DayLiverChallenge #लिवरस्वास्थ्य #StrongLiver @RewariBharat @ArunRastogi9 @gaurav25051981 @thoughtruminant @SukritiBaweja @htevethia @satenderpsingh @ChiefSecyDelhi @LtGovDelhi @CMODelhi @ICMRDELHI @MoHFW_INDIA @Sangram_Sanjeet @DrKanicaKaushal @NTrehanpati @GayatriRamakri4 @AnupamaParasar @ashok_doctor @MaiwallRakhi